Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Salmonella Typhimurium”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Early research (Phase 1)Study completedNCT00004216
What this trial is testing

VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Therapy

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Vion Pharmaceuticals
Testing effectiveness (Phase 2)Looking for participantsNCT05784701
What this trial is testing

Trivalent Salmonella Conjugate Vaccine (TSCV)

Who this might be right for
Trivalent Salmonella Conjugate Vaccine (TSCV)
University of Maryland, Baltimore 800
Early research (Phase 1)Study completedNCT00004988
What this trial is testing

Treatment of Patients With Cancer With Genetically Modified Salmonella Typhimurium Bacteria

Who this might be right for
CancerNeoplasmNeoplasm Metastasis
National Cancer Institute (NCI) 45
Not applicableActive Not RecruitingNCT05870150
What this trial is testing

Challenge Non-Typhoidal Salmonella (CHANTS) Study

Who this might be right for
Salmonella InfectionsSalmonella TyphimuriumNon-typhoidal Salmonella (NTS)+5 more
Imperial College Healthcare NHS Trust 80
Early research (Phase 1)Study completedNCT05525546
What this trial is testing

Salmonella Conjugates CVD 2000: Study of Responses to Vaccination With Trivalent Salmonella Conjugate Vaccine to Prevent Invasive Salmonella Disease

Who this might be right for
Risk Reduction
University of Maryland, Baltimore 82
Testing effectiveness (Phase 2)Active Not RecruitingNCT06213506
What this trial is testing

A Study on the Safety, Reactogenicity, and Immune Response to the GVGH iNTS-GMMA Vaccine Against Invasive Nontyphoidal Salmonella in Adults, Children, and Infants

Who this might be right for
Salmonella Infections
GlaxoSmithKline 215
Testing effectiveness (Phase 2)Looking for participantsNCT05103345
What this trial is testing

Study of SGN1 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumor
Guangzhou Sinogen Pharmaceutical Co., Ltd 70
Early research (Phase 1)Study completedNCT03981952
What this trial is testing

Salmonella Conjugates CVD 1000: Study of Responses to Vaccination With Trivalent Invasive Salmonella Disease Vaccine

Who this might be right for
Risk Reduction
University of Maryland, Baltimore 96
Testing effectiveness (Phase 2)Looking for participantsNCT05038150
What this trial is testing

Study of SGN1 in Patients With Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumor
Guangzhou Sinogen Pharmaceutical Co., Ltd 70
Early research (Phase 1)Study completedNCT00006254
What this trial is testing

VNP20009 in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Vion Pharmaceuticals
Early research (Phase 1)Study completedNCT01099631
What this trial is testing

IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread

Who this might be right for
Cancer of the LiverLiver CancerHepatoma+2 more
Masonic Cancer Center, University of Minnesota 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT04589234
What this trial is testing

Saltikva for Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Salspera LLC 60